PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Right Care: Implications for Pharma

Top Tweets from J.P. Morgan 2017

War Games: Win Your Brand with Action

Advertisement
Top Story
Pharm Exec's Industry Outlook 2017
The populist-driven shifts trumpeted from the US to the EU leaves plenty of question marks when trying to size up the trajectory of the global pharma industry. One certainty, however, will be change
/Read more/
Advertisement
Delayed and confusing IDMP compliance requirements demand life science CIOs pursue a two-part strategy. The deadline for IDMP compliance was July 1 2016, and IDMP compliance is mandatory for MAHs in Europe to operate without fines, but the rollout and standards details are delayed until 2018. Life science IT leaders supporting regulatory compliance can use this Gartner research to set strategies. Learn more
Viewpoint
Connecting the Dots for an Enraged Media
With media commentators stridently voicing their concerns about the Trump administration's plans for Obamacare and FDA, Casey McDonald connects some of the dots that critics have so far overlooked
/Read more/
Advertisement
DCAT Week: Business Development—Networking—Education
DCAT Week is the premier global event for the business of pharmaceutical development and manufacturing (March 20-23 in New York City). Organized by the Drug, Chemical & Associated Technologies Association, its unique model brings together members for high-level strategic meetings with key decision makers, timely educational programs and important networking opportunities. Learn more
Europe
Hardcore Obstacles to Europe's HTA Ambitions
The long-cherished dream of finding a European approach to assessing the value of new medicines seems to recede further with every step taken to pursue it, writes Reflector
/Read more/
Advertisement
From Big Data to Measurable Outcomes: Success with Value-Based Contracts
Live Webinar: Tuesday, January 24 at 3:00pm EST
Register now
Interview
Biopharma Change Agent: Belén Garijo
Belén Garijo, CEO of Merck KGaA, Darmstadt, Germany's healthcare business, shares her approach in transforming a traditional pharma unit focused on small molecules for chronic disease to a high-tech specialty producer of immunotherapy drugs for rare cancers
/Read more/
Calendar
/ March 29–31, 2017: DIA EuroMeeting 2017 /
Glasgow, UK
/ February 08–09, 2017: Speaker Programs 2017 /
Philadelphia, PA
/ March 14–16, 2017: eyeforpharma Barcelona 2017 /
Barcelona, Spain
/ April 26–28, 2017: CBI's 14th Annual Pharmaceutical Compliance Congress /
WASHINGTON, DC
/ June 6–7, 2017: Pharmaceutical Compliance Congress Canada /
Toronto, Canada
/ 20–22 June 2017: EphMRA Annual Conference 2017 /
Amsterdam, The Netherlands
 
Advertisement
Value-Based Engagement Models: Making Collaborations between Pharma and Health Systems Work
Live Webinar: Tuesday, February 7 at 11:00am EST
Register now
Industry update
//Amyris (Emeryville, CA) appointed Kathleen Valiasek as Chief Financial Officer.//Chimerix (Durham, NC) named Randall Lanier, Ph.D, as Chief Science Officer and Roy W. Ware, Ph.D, MBA, as Chief Manufacturing and Technology Officer. //Dermira (Menlo Park, CA) named Lori Lyons-Williams as Chief Commercial Officer.//Pernix Therapeutics Holdings (Morristown, NJ) appointed Ken Piña as Senior Vice President, General Counsel and Chief Compliance Officer. //Voyager Therapeutics (Cambridge, MA) elected Wendy L. Dixon, Ph.D., and Glenn F. Pierce, M.D., Ph.D., to the company's Board of Directors.//
Advertisement
Biologics Manufacturing – Is Your Company Ready?
Live Webinar: Thursday, February 16 at 11:00am EST
Register now
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com